Reported Earlier, MBX Biosciences Prices Initial Public Offering Of 10.20M Common Shares At $16/Share
Portfolio Pulse from Benzinga Newsdesk
MBX Biosciences has priced its initial public offering (IPO) of 10.20 million common shares at $16 per share, expecting to raise $163.2 million. The shares will trade on Nasdaq under the symbol 'MBX' starting September 13, 2024.
September 13, 2024 | 7:27 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MBX Biosciences is launching its IPO with 10.20 million shares priced at $16 each, aiming to raise $163.2 million. The shares will start trading on Nasdaq on September 13, 2024.
The IPO pricing and the expected trading on Nasdaq are significant events for MBX Biosciences, likely to attract investor attention and potentially drive the stock price up in the short term as it enters the public market.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100